Диссертация (1139848), страница 46
Текст из файла (страница 46)
Lancisi. – Rome: Giovanni Maria Salvioni, 1728. – 166 p.214118. Larsson, E. Sudden unexpected cardiac death among young Swedish orienteersmorphological changes in heart and other organs / E. Larsson, L. Wesslen, O. Lindquist et al. //APMIS. –1999. – Vol.
107, № 3. – P. 325–336.119. Lazaros, G. Naxos disease presenting with ventricular tachycardia and troponin elevation /G. Lazaros, A. Anastasakis, D. Tsiachris, P. Dilaveris et al. // Heart Vessels. – 2009. – Vol. 24(1). –P. 63–65.120. Leclercq, J.F. Characteristics, prognosis and treatment of the ventricular arrhythmias ofright ventricular dysplasia / J.F. Leclercq, P. Coumel // Eur.
Heart J. – 1989. – Vol. 10(Suppl D). –P. 61–67.121. Lemola, K. Predictors of adverse outcome in patients with arrhythmogenic rightventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre / K. Lemola,C. Brunckhorst, U. Helfenstein, E.
Oechslin et al. // Heart. – 2005. – Vol. 91(9). – P. 1167–1172.122. Link, M.S. Arrhythmogenic right ventricular dysplasia: clinical results withimplantable cardioverter defibrillators / M.S. Link, P.J. Wang, C.J. Haugh, M.K. Homoud et al. //J. Interv. Card. Electrophysiol. – 1997. – Vol. 1. – P. 41–48.123. Link, M.S.
Ventricular arrhythmias in the North American multidisciplinary study ofARVC: predictors, characteristics, and treatment / M.S. Link, D. Laidlaw, B. Polonsky, W. Zareba etal. / J. Am. Coll. Cardiol. – 2014. – Vol. 64(2). – P. 119–125.124. Lobo, F.V. Right ventricular dysplasia: morphological findings in 13 cases / F.V. Lobo,H.A. Heggtveit, J. Butany, M.D. Silver, J.E. Edwards // Can. J. Cardiol. – 1992. –Vol. 8(3). – P. 261–268.125. Lombardi, R. Genetic fate mapping identifies second heart field progenitor cells as asource of adipocytes in arrhythmogenic right ventricular cardiomyopathy / R.
Lombardi, J. Dong,G. Rodriguez et al. // Circ. Res. – 2009. – Vol. 104(9). – P. 1076–1084.126. Lopez-Ayala, J.M. A mutation in the Z-line Cypher/ZASP protein is associated witharrhythmogenic right ventricular cardiomyopathy / J.M. Lopez-Ayala, M. Ortiz-Genga, I. GomezMilanes / Clin. Genet. – 2015. – Vol. 88(2). – P. 172–176.127.
Lopez-Ayala, J.M. Desmoplakin truncations and arrhythmogenic left ventricularcardiomyopathy: haracterizing a phenotype / J.M. Lopez-Ayala, I. Gomez-Milanes, J.J. SanchezMunoz, F. Ruiz-Espejo et al. // Europace. – 2014. – Vol. 16(12). – P. 1838–1846.128. Mallat, Z. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia / Z. Mallat,A. Tedjin, F. Fontaliran et al. // N. Engl. J. Med. – 1996. – Vol. 335(16).
– P. 1190–1196.129. Marcus, F. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/ dysplasia /F. Marcus, W. McKenna, D. Sherrill, C. Basso et al. // Eur Heart J. – 2010. – Vol. 31. – P. 806–814.130. Marcus, F. The Mystery of Arrhythmogenic Right Ventricular Dysplasia/ Cardiomyopathy From Observation to Mechanistic Explanation / F. Marcus, J.A. Towbin // Circulation. –2006.
– Vol. 114. – P. 1794–1795.215131. Marcus, F.I. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review /F.I. Marcus, G. Fontaine // Pacing Clin. Electrophysiol. – 1995. – Vol. 18(6). – P. 1298–1314.132. Marcus, F.I. Long-term follow-up in patients with arrhythmogenic right ventriculardisease / F.I. Marcus, G.H. Fontaine, R. Frank, J.J. Gallagher, M.J.
Reiter // Eur Heart J. – 1989. –Vol. 10(suppl D). – P. 68 –73.133. Marcus, F.I. Right ventricular dysplasia: a report of 24 adult cases / F.I. Marcus,G.H. Fontaine, G. Guiraudon, R. Frank et al. // Circulation. – 1982. – Vol. 65(2). – P. 384–398.134. Marcus, F.I. Strengths and weaknesses of the task force criteria: proposed modifications inarrhythmogenic right ventricular cardiomyopathy/dysplasia / F.I. Marcus, D.
Sherrill // ArrhythmogenicRight Ventricular Cardiomyopathy Dysplasia / Ed. By: F.I. Marcus, A. Nava, G. Thiene. – Milan, Italy:Springer Verlag, 2007. – Р. 97–104.135. Marcus, G.M. Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right VentricularCardiomyopathy: A Report From the North American ARVC Registry / G.M. Marcus, D.V. Glidden,B.
Polonsky, W. Zareba et al. // J. Am. Coll. Cardiol. – 2009. – Vol. 54(7). – P. 609–615.136. Marra, M.P. Imaging study of ventricular scar in arrhythmogenic right ventricularcardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrastenhanced cardiac magnetic resonance / M.P. Marra, L. Leoni, B. Bauce et al.
// Circ. Arrhythm.Electrophysiol. – 2012. – Vol. 5(1). – P. 91–100.137. Matsumori, А. Coxsackie virus B3 perimyocarditis in the right ventricle /А. Matsumori, C. Kawai // J. Pathology – 1980. – Vol. 131(2). – P. 97–106.138. Mayosi, B.M. Identification of Cadherin 2 (CDH2) Mutations in ArrhythmogenicRight Ventricular Cardiomyopathy / B.M. Mayosi, M. Fish, G. Shaboodien, E. Mastantuono et al.
//Circ. Cardiovasc. Genet. – 2017. – Vol. 10(2). – URL: https://www.ahajournals.org/lookup/doi/10.1161/CIRCGENETICS.116.001605.139. Mazzanti, A. Arrhythmogenic Right Ventricular Сardiomyopathy. Clinical Course andPredictors of Arrhythmic Risk / A. Mazzanti, K. Ng, A. Faragli, R. Maragna et al. // J.
Am. Coll.Cardiol. – 2016. –Vol. 68(23). – P. 2540–2550.140. McKenna, W.J. Diagnosis of arrhythmogenic right ventricular dysplasia/ cardiomyopathy.Task Force of the Working Group Myocardial and Pericardial Disease of the European Society ofCardiology and of the Scientific Council on Cardiomyopathies of the International Society andFederation of Cardiology / W.J. McKenna, G. Thiene, A. Nava, F. Fontaliran et al. // Br. Heart J. –1994. – Vol. 71(3). – P. 215–218.141.
McKoy, G. Identification of a deletion in plakoglobin in arrhythmogenic rightventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) /G. McKoy, N. Protonotarios, A. Crosby, A. Tsatsopoulou et al. // Lancet. – 2000. –Vol. 17(9221). – P. 2119–2124.216142. Migliore, F.
Prognostic value of endocardial voltage mapping in patients witharrhythmogenic right ventricular cardiomyopathy/dysplasia / F. Migliore, A. Zorzi, M. Silvano,M. Bevilacqua et al. // Circ. Arrhythm. Electrophysiol. – 2013. –Vol. 6(1). – P. 167–176.143. Möhr, A.J. Arrhythmogenic right ventricular cardiomyopathy in a dog / A.J. Möhr,R.M. Kirberger // J. S. Afr. Vet. Assoc.
– 2000. – Vol. 71(2). – P. 125–130.144. Murray, B. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): areview of molecular and clinical literature / B. Murray // J.Genet. Couns. – 2012. – Vol. 21(4). –P. 494–504.145. Naccarella, F. Malignant ventricular arrhythmias in patients with right bundle branchblock and persistent ST segment elevation in V1-V3; a probable arrhythmogenic cardiomyopathy ofright ventricle / F. Naccarella // G. Ital. Cardiol.
– 1993. – Vol. 23(12). – P. 1219–1222.146. Nademanee, K. Arrhythmogenic marker for the sudden unexplained death syndrome inThai men / K. Nademanee, G. Veerakul, S. Nimmannit, V. Chaowakul et al. // Circulation. – 1997. –Vol. 96(8). – P. 2595–2600.147. Nasir, K. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria / K. Nasir,C. Bomma, H.
Tandri et al. // Circulation. – 2004. – Vol. 10(12). – P. 1527–1534.148. Nava, A. Clinical profile and long-term follow-up of 37 families with arrhythmogenicright ventricular cardiomyopathy / A. Nava, B. Bauce, C. Basso, M. Muriago et al. // J. Am.
Coll.Cardiol. – 2000. – Vol. 36(7). – P. 2226–2233.149. Nava, A. Familial occurrence of right ventricular dysplasia: a study involving ninefamilies / A. Nava, G. Thiene, B. Canciani et al. // J. Am. Coll. Cardiol. – 1988. – Vol. 12(5). –P. 1222–1228.150. Norgett, E.E. Recessive mutation in desmoplakin disrupts desmoplakin-intermediatefilament interactions and causes dilated cardiomyopathy, wooly hair and keratoderma /E.E.
Norgett, S.J. Hatsell, L. Carvajal-Huerta, J.C. Cabezas et al. // Hum. Mol. Genet. – 2000. –Vol. 9(18). – P. 2761–2766.151. Norman, M. Novel mutation in desmoplakin causes arrhythmogenic left ventricularcardiomyopathy / M. Norman, M. Simpson, J. Mogensen, A. Shaw et al. // Circulation. – 2005. –Vol. 112(5). – P. 636–642.152. Norman, M.W. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: perspectiveson disease / M.W. Norman, W.J. McKenna // Z.
Kardiol. – 1999. – Vol. 88(8). – P. 550–554.153. Okada, R. Pathology of the conduction system in Pokkuri disease (sudden death ofunknown etiology in young men) / R. Okada, K. Gotoh // Cardiac Arrhythmias: Recent Progress inInvestigation and Management / Ed. by: T. Iwa, G. Fontaine. – Hague, Netherlands: Elsevier SciencePublishers, 1988. – P. 177–188.217154. Pai, J.K. Inflammatory markers and the risk of coronary heart disease in men andwomen / J. K. Pai, T. Pischon, J. Ma et al. // The New England Journal of Medicine. – 2004.
– Vol.351, no. 25. – P. 2599–2610.155. Patel, H.C. Arrhythmogenic right ventricular dysplasia / H.C. Patel, H. Calkins // Curr.Treat. Options Cardiovasc. Med. – 2010. – Vol. 12(6). – P. 598–613.156. Patrianakos, A.P. Arrhythmogenic right ventricular cardiomyopathy/dysplasia andtroponin release.
Myocarditis or the “hot phase” of the disease? / A.P. Patrianakos,N. Protonotarios, E. Nyktari, K. Pagonidis et al. // International Journal of Cardiology. – 2012. –Vol. 157, Issue 2. – P. e26–e28.157. Paul, M. Arrhythmogenic right ventricular cardiomyopathy: an update on pathophysiology, genetics, diagnosis, and risk stratification / M. Paul, T. Wichter, L. Fabritz, J. Waltenbergeret al. // Herzschrittmacherther Elektrophysiol. – 2012.
– Vol. 23(3). – P. 186–195.158. Peters, S. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referralhospital / S. Peters, M. Trümmel, W. Meyners // International Journal of Cardiology. – 2004. –Vol. 97(3), Dec. – P. 499–501.159. Peters, S. Risk stratification of sudden cardiac death and malignant ventricular arrhythmiasin right ventricular dysplasia-cardiomyopathy / S.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
